// App-Quantinova.ai

1538 : Contribution of the TP53 R337H mutation to the cancer burden in families with a proband with adrenocortical tumor.

Researchers

Presenter

  • Maria Jose Mastellaro

Principal Investigators

  • Guolian Kang

  • Ana Luiza Seidinger

  • Eliana C. M. Miranda

  • Renata Abrah A

  • Bonald Cavalcante de Figueiredo

  • Carlos Rodriguez-Galindo

  • Jose A Yunes

  • Antonio A Barros

  • Raul Correa Ribeiro

Medical Centers

  • Department of Post-Graduation in Children and Adolescents Health, University of Campinas, and Department of Pediatric Oncology, Boldrini Children's Center, Sao Paulo, Brazil

  • St. Jude Children's Research Hospital, Memphis, TN

  • Department of Molecular Biology, Boldrini Children's Center, Campinas, Sao Paulo, Brazil, Campinas, Brazil

  • Data Center and Statistics, Hematology and Hemotherapy Department, University of Campinas, Campinas, Sao Paulo, Brazil, Campinas, Brazil

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Federal University of Parana , Curitiba, and Instituto de Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil, Curitiba, Brazil

  • Dana-Farber Cancer Institute, Children's Hospital, Boston, MA

  • Centro Infantil Boldrini, San Paulo, Brazil

  • Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, Sao Paulo, Brazil, Campinas, Brazil

Locations

  • Brazil

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adrenal carcinoma

  • Solid malignancies

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved